LH
38
5
HIG
51
4
FE
37
3
BMY
33
-2
NTRS
44
5
PPL
47
3
MTCH
57
2
EQT
48
6
MA
64
2
CL
50
3
L
59
4
GD
44
2
BF.B
35
2
STT
64
5
SIG
55
3
BBY
52
4
LB
30
11
EOG
32
3
R
61
2
HP
38
4
LH
38
5
HIG
51
4
FE
37
3
BMY
33
-2
NTRS
44
5
PPL
47
3
MTCH
57
2
EQT
48
6
MA
64
2
CL
50
3
L
59
4
GD
44
2
BF.B
35
2
STT
64
5
SIG
55
3
BBY
52
4
LB
30
11
EOG
32
3
R
61
2
HP
38
4
Financhill
Back

Virtus LifeSci Biotech Clinical Trials ETF Stock Predictions

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here
Sell
40

BBC
Virtus LifeSci Biotech Clinical Trials ETF

Last Price:
$24.42
Seasonality Move:
-1.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Virtus LifeSci Biotech Clinical Trials ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 3.5% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
  • Is Virtus LifeSci Biotech Clinical Trials ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trials ETF [BBC] share price is $24.49. The Score for BBC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trials ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trials ETF has on average historically risen by 3.5% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trials ETF Stock Rating

Sell
40
Virtus LifeSci Biotech Clinical Trials ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trials ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trials ETF has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
23.66

Prediction Charts

Market Cap:
0
Price in USD:
24.49
Volume:
2.3K
Beta:
1.28

Technical Analysis

SMA50:
27.91
SMA100:
27.71
SMA200:
27.49
52-Wk Change:
3.66%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trials ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trials ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trials ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trials ETF stock price is 24.49 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trials ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trials ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 26.84 26.93 27.10 26.77
Dec-5 26.59 26.29 26.65 26.28
Dec-6 26.64 27.32 27.36 26.64
Dec-9 27.28 27.08 27.33 27.08
Dec-10 27.44 27.17 27.49 27.10
Dec-11 27.21 26.97 27.21 26.69
Dec-12 26.50 25.56 26.58 25.56
Dec-13 25.12 25.05 25.12 25.02
Dec-16 25.18 25.55 25.68 25.18
Dec-17 25.39 25.49 25.56 25.37
Dec-18 24.94 23.90 25.22 23.84
Dec-19 24.03 24.23 24.38 23.96
Dec-20 24.13 24.33 24.52 24.13
Dec-24 24.29 24.49 24.49 24.16

Virtus LifeSci Biotech Clinical Trials ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trials ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trials ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.